7-year follow-up of AATT study
Efficacy of odronextamab
Risk of late and very late leukaemia
Venetoclax plus decitabine as first-line therapy
Asciminib for chronic-phase chronic myeloid leukaemia
Describing outcomes of giltertinib
Ibrutinib plus RminiCHOP
Comparison of gilteritinib and sorafenib
Safety of rituximab plus high-dose methotrexate
R-CHOP versus R-CHOEP
Please login below to download this issue (PDF)